

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.83266486 |
| 2 | cardiac myofibril assembly (GO:0055003) | 7.99528513 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.65365400 |
| 4 | myofibril assembly (GO:0030239) | 7.49705439 |
| 5 | muscle filament sliding (GO:0030049) | 7.38850727 |
| 6 | actin-myosin filament sliding (GO:0033275) | 7.38850727 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.16642993 |
| 8 | tricarboxylic acid cycle (GO:0006099) | 6.87382388 |
| 9 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.80888824 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.77573803 |
| 11 | regulation of skeletal muscle contraction (GO:0014819) | 6.63655184 |
| 12 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.51536882 |
| 13 | regulation of relaxation of muscle (GO:1901077) | 6.45810381 |
| 14 | cardiac muscle contraction (GO:0060048) | 6.45295267 |
| 15 | plasma membrane repair (GO:0001778) | 6.44512471 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.27194437 |
| 17 | actin-mediated cell contraction (GO:0070252) | 6.08152118 |
| 18 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 6.00414785 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 5.99745295 |
| 20 | cardiac muscle cell development (GO:0055013) | 5.85567394 |
| 21 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.74525892 |
| 22 | carnitine shuttle (GO:0006853) | 5.57770208 |
| 23 | actomyosin structure organization (GO:0031032) | 5.52975540 |
| 24 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.50951312 |
| 25 | regulation of cell communication by electrical coupling (GO:0010649) | 5.50136899 |
| 26 | cardiac cell development (GO:0055006) | 5.48895188 |
| 27 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.47894430 |
| 28 | striated muscle contraction (GO:0006941) | 5.44281701 |
| 29 | regulation of sarcomere organization (GO:0060297) | 5.22681121 |
| 30 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.21959332 |
| 31 | cardiac muscle hypertrophy (GO:0003300) | 5.21788997 |
| 32 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.18320108 |
| 33 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.15318183 |
| 34 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.10658311 |
| 35 | striated muscle hypertrophy (GO:0014897) | 5.01108741 |
| 36 | regulation of cofactor metabolic process (GO:0051193) | 4.98191536 |
| 37 | regulation of coenzyme metabolic process (GO:0051196) | 4.98191536 |
| 38 | adult heart development (GO:0007512) | 4.94175736 |
| 39 | fatty acid transmembrane transport (GO:1902001) | 4.88245350 |
| 40 | heart trabecula formation (GO:0060347) | 4.86042036 |
| 41 | heart process (GO:0003015) | 4.82773216 |
| 42 | heart contraction (GO:0060047) | 4.82773216 |
| 43 | regulation of striated muscle contraction (GO:0006942) | 4.81471137 |
| 44 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.73957610 |
| 45 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.67447321 |
| 46 | muscle tissue morphogenesis (GO:0060415) | 4.65264238 |
| 47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.61411801 |
| 48 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.61384572 |
| 49 | actin filament-based movement (GO:0030048) | 4.54373342 |
| 50 | skeletal muscle contraction (GO:0003009) | 4.50548524 |
| 51 | regulation of membrane repolarization (GO:0060306) | 4.46343452 |
| 52 | muscle hypertrophy (GO:0014896) | 4.43188435 |
| 53 | respiratory electron transport chain (GO:0022904) | 4.37587406 |
| 54 | cell communication involved in cardiac conduction (GO:0086065) | 4.27838134 |
| 55 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.27721289 |
| 56 | ATP synthesis coupled proton transport (GO:0015986) | 4.27721289 |
| 57 | electron transport chain (GO:0022900) | 4.24224635 |
| 58 | 2-oxoglutarate metabolic process (GO:0006103) | 4.21544288 |
| 59 | regulation of the force of heart contraction (GO:0002026) | 4.20561788 |
| 60 | NADH metabolic process (GO:0006734) | 4.19125688 |
| 61 | oxidative phosphorylation (GO:0006119) | 4.17191534 |
| 62 | carnitine transmembrane transport (GO:1902603) | 4.16779406 |
| 63 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.11877376 |
| 64 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.09921318 |
| 65 | regulation of sulfur metabolic process (GO:0042762) | 4.06424566 |
| 66 | regulation of sequestering of triglyceride (GO:0010889) | 4.01702926 |
| 67 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.01149921 |
| 68 | * creatine metabolic process (GO:0006600) | 3.94685932 |
| 69 | regulation of cardiac muscle contraction (GO:0055117) | 3.91738759 |
| 70 | muscle fiber development (GO:0048747) | 3.91408639 |
| 71 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.88817773 |
| 72 | skeletal muscle fiber development (GO:0048741) | 3.87947080 |
| 73 | glycogen catabolic process (GO:0005980) | 3.83028480 |
| 74 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.82765581 |
| 75 | muscle hypertrophy in response to stress (GO:0003299) | 3.82765581 |
| 76 | cardiac muscle adaptation (GO:0014887) | 3.82765581 |
| 77 | carnitine transport (GO:0015879) | 3.80040789 |
| 78 | amino-acid betaine transport (GO:0015838) | 3.80040789 |
| 79 | skeletal muscle adaptation (GO:0043501) | 3.78088170 |
| 80 | relaxation of cardiac muscle (GO:0055119) | 3.78051840 |
| 81 | negative regulation of potassium ion transport (GO:0043267) | 3.74880157 |
| 82 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.71789044 |
| 83 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.71295134 |
| 84 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.71295134 |
| 85 | * muscle contraction (GO:0006936) | 3.70299235 |
| 86 | cardiac muscle cell action potential (GO:0086001) | 3.69554423 |
| 87 | regulation of ATP catabolic process (GO:1903289) | 3.68563423 |
| 88 | regulation of ATPase activity (GO:0043462) | 3.68563423 |
| 89 | regulation of heart rate (GO:0002027) | 3.67747410 |
| 90 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.64351823 |
| 91 | myotube cell development (GO:0014904) | 3.64318908 |
| 92 | glucan biosynthetic process (GO:0009250) | 3.64123608 |
| 93 | glycogen biosynthetic process (GO:0005978) | 3.64123608 |
| 94 | striated muscle adaptation (GO:0014888) | 3.63469020 |
| 95 | response to inactivity (GO:0014854) | 3.62819779 |
| 96 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.62629127 |
| 97 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.61108326 |
| 98 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.61108326 |
| 99 | regulation of muscle contraction (GO:0006937) | 3.60418107 |
| 100 | glucan catabolic process (GO:0009251) | 3.58951249 |
| 101 | striated muscle cell development (GO:0055002) | 3.56734240 |
| 102 | positive regulation of cation channel activity (GO:2001259) | 3.55227822 |
| 103 | negative regulation of protein localization to cell surface (GO:2000009) | 3.52319464 |
| 104 | muscle adaptation (GO:0043500) | 3.51782149 |
| 105 | fatty acid beta-oxidation (GO:0006635) | 3.50530995 |
| 106 | regulation of muscle system process (GO:0090257) | 3.50473806 |
| 107 | aspartate family amino acid catabolic process (GO:0009068) | 3.49752585 |
| 108 | cell communication by electrical coupling (GO:0010644) | 3.49274155 |
| 109 | * muscle system process (GO:0003012) | 3.46911415 |
| 110 | skeletal muscle tissue development (GO:0007519) | 3.46250736 |
| 111 | detection of calcium ion (GO:0005513) | 3.46127376 |
| 112 | succinate metabolic process (GO:0006105) | 3.44563531 |
| 113 | oxygen transport (GO:0015671) | 3.44442742 |
| 114 | response to caffeine (GO:0031000) | 3.44412726 |
| 115 | positive regulation of heart rate (GO:0010460) | 3.43168256 |
| 116 | response to epinephrine (GO:0071871) | 3.41534083 |
| 117 | regulation of heart contraction (GO:0008016) | 3.41338801 |
| 118 | muscle cell cellular homeostasis (GO:0046716) | 3.38244414 |
| 119 | regulation of fatty acid oxidation (GO:0046320) | 3.38134845 |
| 120 | response to muscle activity (GO:0014850) | 3.37899170 |
| 121 | cellular polysaccharide catabolic process (GO:0044247) | 3.36218569 |
| 122 | cardiac conduction (GO:0061337) | 3.33095267 |
| 123 | relaxation of muscle (GO:0090075) | 3.31743967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.22389557 |
| 2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.73579557 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.57403033 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.38512210 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.08297329 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.08297329 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.36824294 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.27117834 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.20390261 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.08860436 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.89929185 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.82807189 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.37403770 |
| 14 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.31730254 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.22610061 |
| 16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.21207127 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.20954264 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.14598105 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.05226193 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.04129158 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.89181628 |
| 22 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.82106515 |
| 23 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.78163860 |
| 24 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.74395074 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70448142 |
| 26 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.67053479 |
| 27 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.63136230 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58983130 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51429466 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51166953 |
| 31 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.43248413 |
| 32 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42940267 |
| 33 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.42217345 |
| 34 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.41392931 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38043903 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38024727 |
| 37 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.34817691 |
| 38 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34455033 |
| 39 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.29854489 |
| 40 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.26179885 |
| 41 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.25036467 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22430334 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17284509 |
| 44 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16911867 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.15261741 |
| 46 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14178001 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13053127 |
| 48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11992325 |
| 49 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11794212 |
| 50 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.10510565 |
| 51 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09437571 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07612874 |
| 53 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06530945 |
| 54 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05572731 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05484814 |
| 56 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.05040259 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03163803 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02846523 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01319058 |
| 60 | P68_20966046_ChIP-Seq_HELA_Human | 0.97406366 |
| 61 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97020300 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96317154 |
| 63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95644161 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95585681 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95459750 |
| 66 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95197951 |
| 67 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.94337851 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94249225 |
| 69 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93866728 |
| 70 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.93847853 |
| 71 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93278646 |
| 72 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.93227440 |
| 73 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92936255 |
| 74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92765203 |
| 75 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.91538034 |
| 76 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.90633514 |
| 77 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.90378563 |
| 78 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89041714 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88831248 |
| 80 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87926318 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87500739 |
| 82 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.87393320 |
| 83 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.87039205 |
| 84 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86475693 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85680380 |
| 86 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85481111 |
| 87 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85281848 |
| 88 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.84007661 |
| 89 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.83350088 |
| 90 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.83186848 |
| 91 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83148233 |
| 92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83145722 |
| 93 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.82975588 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82533873 |
| 95 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82507415 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82455939 |
| 97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82455939 |
| 98 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82385605 |
| 99 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.81827276 |
| 100 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.81827276 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.81587645 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80615357 |
| 103 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80590331 |
| 104 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.80368179 |
| 105 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80005176 |
| 106 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.79966447 |
| 107 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.79419659 |
| 108 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.79380842 |
| 109 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.79119700 |
| 110 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.78907870 |
| 111 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78895261 |
| 112 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.78744420 |
| 113 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.78259827 |
| 114 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.77906377 |
| 115 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.77788571 |
| 116 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.77287702 |
| 117 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.76802588 |
| 118 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76475894 |
| 119 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.76168191 |
| 120 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.75892625 |
| 121 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.75758701 |
| 122 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75177192 |
| 123 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.74690424 |
| 124 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.74101358 |
| 125 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.73930056 |
| 126 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.73615492 |
| 127 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.73079560 |
| 128 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.72207355 |
| 129 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72007240 |
| 130 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.71367081 |
| 131 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.71316710 |
| 132 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.71167888 |
| 133 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.71164163 |
| 134 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.70991478 |
| 135 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70813927 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70686667 |
| 137 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.70427703 |
| 138 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70251857 |
| 139 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.69996458 |
| 140 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.69815296 |
| 141 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.69730703 |
| 142 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.69422423 |
| 143 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.68795658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.71564312 |
| 2 | MP0003646_muscle_fatigue | 6.27884318 |
| 3 | MP0000751_myopathy | 5.41119378 |
| 4 | MP0004084_abnormal_cardiac_muscle | 5.29474784 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.53388893 |
| 6 | MP0000749_muscle_degeneration | 4.28988515 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.27874728 |
| 8 | MP0005330_cardiomyopathy | 3.79760943 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.20522280 |
| 10 | MP0002972_abnormal_cardiac_muscle | 2.95671335 |
| 11 | MP0004130_abnormal_muscle_cell | 2.94647306 |
| 12 | MP0004145_abnormal_muscle_electrophysio | 2.92162877 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.88249916 |
| 14 | MP0002106_abnormal_muscle_physiology | 2.79871318 |
| 15 | MP0005620_abnormal_muscle_contractility | 2.77953071 |
| 16 | MP0008775_abnormal_heart_ventricle | 2.73442253 |
| 17 | MP0003137_abnormal_impulse_conducting | 2.62891400 |
| 18 | MP0004484_altered_response_of | 2.61848423 |
| 19 | MP0002269_muscular_atrophy | 2.52979903 |
| 20 | MP0010630_abnormal_cardiac_muscle | 2.47043682 |
| 21 | * MP0001544_abnormal_cardiovascular_syste | 2.39102883 |
| 22 | * MP0005385_cardiovascular_system_phenoty | 2.39102883 |
| 23 | MP0000747_muscle_weakness | 2.36249962 |
| 24 | MP0005369_muscle_phenotype | 2.28086454 |
| 25 | MP0000759_abnormal_skeletal_muscle | 2.27368837 |
| 26 | MP0006138_congestive_heart_failure | 2.17709134 |
| 27 | MP0003828_pulmonary_edema | 1.99166361 |
| 28 | MP0003221_abnormal_cardiomyocyte_apopto | 1.98900470 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 1.97485675 |
| 30 | MP0004085_abnormal_heartbeat | 1.92697056 |
| 31 | MP0004233_abnormal_muscle_weight | 1.82105749 |
| 32 | MP0004510_myositis | 1.76120868 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.65145713 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.58893811 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.43092355 |
| 36 | MP0005670_abnormal_white_adipose | 1.25908098 |
| 37 | MP0000343_altered_response_to | 1.24396667 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.22744558 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 1.13728840 |
| 40 | MP0005165_increased_susceptibility_to | 1.09073610 |
| 41 | MP0005375_adipose_tissue_phenotype | 1.07979301 |
| 42 | * MP0002127_abnormal_cardiovascular_syste | 1.07623430 |
| 43 | MP0002234_abnormal_pharynx_morphology | 1.07612303 |
| 44 | MP0003567_abnormal_fetal_cardiomyocyte | 1.05201174 |
| 45 | MP0002108_abnormal_muscle_morphology | 1.04826894 |
| 46 | * MP0000266_abnormal_heart_morphology | 1.04221758 |
| 47 | MP0001661_extended_life_span | 0.97419856 |
| 48 | MP0005266_abnormal_metabolism | 0.94224665 |
| 49 | MP0010368_abnormal_lymphatic_system | 0.91035918 |
| 50 | MP0003279_aneurysm | 0.82706405 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 0.78977730 |
| 52 | MP0004270_analgesia | 0.78522110 |
| 53 | MP0000733_abnormal_muscle_development | 0.78421486 |
| 54 | MP0004043_abnormal_pH_regulation | 0.77784191 |
| 55 | MP0002971_abnormal_brown_adipose | 0.70126739 |
| 56 | MP0004147_increased_porphyrin_level | 0.67853520 |
| 57 | * MP0000230_abnormal_systemic_arterial | 0.66747946 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 0.65514753 |
| 59 | * MP0002128_abnormal_blood_circulation | 0.65469614 |
| 60 | MP0000013_abnormal_adipose_tissue | 0.65373430 |
| 61 | MP0000003_abnormal_adipose_tissue | 0.63561646 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 0.62567021 |
| 63 | MP0002909_abnormal_adrenal_gland | 0.61685892 |
| 64 | MP0001879_abnormal_lymphatic_vessel | 0.58899774 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 0.56237586 |
| 66 | MP0003566_abnormal_cell_adhesion | 0.56118090 |
| 67 | MP0005623_abnormal_meninges_morphology | 0.55585458 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 0.51725303 |
| 69 | MP0005187_abnormal_penis_morphology | 0.51023758 |
| 70 | MP0008569_lethality_at_weaning | 0.49360367 |
| 71 | MP0008961_abnormal_basal_metabolism | 0.49154034 |
| 72 | MP0002638_abnormal_pupillary_reflex | 0.48107352 |
| 73 | MP0000767_abnormal_smooth_muscle | 0.46938508 |
| 74 | MP0005275_abnormal_skin_tensile | 0.45442616 |
| 75 | MP0005535_abnormal_body_temperature | 0.42423852 |
| 76 | MP0001299_abnormal_eye_distance/ | 0.41740937 |
| 77 | MP0005451_abnormal_body_composition | 0.41548975 |
| 78 | MP0002822_catalepsy | 0.41155004 |
| 79 | MP0000372_irregular_coat_pigmentation | 0.39656281 |
| 80 | MP0008438_abnormal_cutaneous_collagen | 0.36855701 |
| 81 | MP0003195_calcinosis | 0.36830515 |
| 82 | MP0005334_abnormal_fat_pad | 0.36649564 |
| 83 | MP0009840_abnormal_foam_cell | 0.35532342 |
| 84 | MP0002925_abnormal_cardiovascular_devel | 0.35172472 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 0.31876341 |
| 86 | MP0005083_abnormal_biliary_tract | 0.31732290 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.30506991 |
| 88 | MP0001614_abnormal_blood_vessel | 0.28961433 |
| 89 | MP0001984_abnormal_olfaction | 0.28756732 |
| 90 | MP0005386_behavior/neurological_phenoty | 0.28253698 |
| 91 | MP0004924_abnormal_behavior | 0.28253698 |
| 92 | MP0003948_abnormal_gas_homeostasis | 0.28088623 |
| 93 | MP0001853_heart_inflammation | 0.27829531 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.27707754 |
| 95 | MP0003045_fibrosis | 0.27073170 |
| 96 | MP0003984_embryonic_growth_retardation | 0.26004107 |
| 97 | MP0001784_abnormal_fluid_regulation | 0.25348431 |
| 98 | MP0004272_abnormal_basement_membrane | 0.25014454 |
| 99 | MP0009115_abnormal_fat_cell | 0.25004115 |
| 100 | MP0002088_abnormal_embryonic_growth/wei | 0.24682323 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.24567382 |
| 102 | MP0001727_abnormal_embryo_implantation | 0.23825349 |
| 103 | MP0009384_cardiac_valve_regurgitation | 0.23536839 |
| 104 | MP0003879_abnormal_hair_cell | 0.23428500 |
| 105 | MP0008004_abnormal_stomach_pH | 0.22370170 |
| 106 | MP0002877_abnormal_melanocyte_morpholog | 0.21706055 |
| 107 | MP0000249_abnormal_blood_vessel | 0.21393245 |
| 108 | MP0005332_abnormal_amino_acid | 0.21282173 |
| 109 | MP0005376_homeostasis/metabolism_phenot | 0.21074338 |
| 110 | MP0000762_abnormal_tongue_morphology | 0.21044088 |
| 111 | MP0005452_abnormal_adipose_tissue | 0.20548152 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.20516089 |
| 113 | MP0005409_darkened_coat_color | 0.20261168 |
| 114 | MP0004134_abnormal_chest_morphology | 0.17521805 |
| 115 | MP0004142_abnormal_muscle_tone | 0.17271418 |
| 116 | MP0002896_abnormal_bone_mineralization | 0.17118044 |
| 117 | MP0008874_decreased_physiological_sensi | 0.16399063 |
| 118 | MP0002066_abnormal_motor_capabilities/c | 0.15370804 |
| 119 | MP0005166_decreased_susceptibility_to | 0.15273192 |
| 120 | MP0009672_abnormal_birth_weight | 0.15145963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.16856885 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 6.76004076 |
| 3 | Exercise-induced myalgia (HP:0003738) | 6.64693755 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.45636473 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.44572008 |
| 6 | Ventricular tachycardia (HP:0004756) | 6.41990198 |
| 7 | Muscle fiber splitting (HP:0003555) | 5.77704369 |
| 8 | Atrial fibrillation (HP:0005110) | 5.42977682 |
| 9 | Myoglobinuria (HP:0002913) | 5.42817840 |
| 10 | Abnormality of the calf musculature (HP:0001430) | 5.25982089 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 5.19303661 |
| 12 | Primary atrial arrhythmia (HP:0001692) | 5.07810456 |
| 13 | Supraventricular tachycardia (HP:0004755) | 4.90956172 |
| 14 | Lipoatrophy (HP:0100578) | 4.80294577 |
| 15 | Supraventricular arrhythmia (HP:0005115) | 4.79825938 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 4.52780321 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.45099041 |
| 18 | Bundle branch block (HP:0011710) | 4.44147234 |
| 19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.42095934 |
| 20 | Subaortic stenosis (HP:0001682) | 4.42095934 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 4.33618179 |
| 22 | Rhabdomyolysis (HP:0003201) | 4.20113709 |
| 23 | Increased connective tissue (HP:0009025) | 4.20056690 |
| 24 | Syncope (HP:0001279) | 4.18631857 |
| 25 | Palpitations (HP:0001962) | 4.15733496 |
| 26 | Difficulty running (HP:0009046) | 4.13646998 |
| 27 | Dilated cardiomyopathy (HP:0001644) | 4.10993837 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.90774784 |
| 29 | Muscle fiber inclusion bodies (HP:0100299) | 3.88910334 |
| 30 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.74185874 |
| 31 | Prolonged QT interval (HP:0001657) | 3.70595190 |
| 32 | Myotonia (HP:0002486) | 3.67882572 |
| 33 | Heart block (HP:0012722) | 3.65310228 |
| 34 | Ventricular arrhythmia (HP:0004308) | 3.51865096 |
| 35 | Abnormal atrioventricular conduction (HP:0005150) | 3.44683403 |
| 36 | Atrioventricular block (HP:0001678) | 3.37436984 |
| 37 | Ulnar deviation of the wrist (HP:0003049) | 3.30154559 |
| 38 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.18491366 |
| 39 | Acute necrotizing encephalopathy (HP:0006965) | 3.15199927 |
| 40 | Difficulty climbing stairs (HP:0003551) | 3.12579374 |
| 41 | Type 1 muscle fiber predominance (HP:0003803) | 3.09573583 |
| 42 | Muscle stiffness (HP:0003552) | 3.09544440 |
| 43 | Nemaline bodies (HP:0003798) | 3.07952454 |
| 44 | Frequent falls (HP:0002359) | 3.06962346 |
| 45 | Hepatic necrosis (HP:0002605) | 3.05618113 |
| 46 | Ventricular fibrillation (HP:0001663) | 3.02555614 |
| 47 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.96944054 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.92958772 |
| 49 | Areflexia of lower limbs (HP:0002522) | 2.84793136 |
| 50 | Increased variability in muscle fiber diameter (HP:0003557) | 2.84258473 |
| 51 | Ketoacidosis (HP:0001993) | 2.83094845 |
| 52 | Calcaneovalgus deformity (HP:0001848) | 2.82921252 |
| 53 | Acute encephalopathy (HP:0006846) | 2.74227337 |
| 54 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.73147505 |
| 55 | Left ventricular hypertrophy (HP:0001712) | 2.70707404 |
| 56 | Hypoglycemic coma (HP:0001325) | 2.65898398 |
| 57 | Abnormal EKG (HP:0003115) | 2.65776564 |
| 58 | Hepatocellular necrosis (HP:0001404) | 2.64283607 |
| 59 | Progressive macrocephaly (HP:0004481) | 2.63841648 |
| 60 | Absent phalangeal crease (HP:0006109) | 2.62193087 |
| 61 | Neck muscle weakness (HP:0000467) | 2.55202974 |
| 62 | Limb-girdle muscle atrophy (HP:0003797) | 2.51235883 |
| 63 | Cerebral edema (HP:0002181) | 2.50804334 |
| 64 | Scapular winging (HP:0003691) | 2.50686644 |
| 65 | Rimmed vacuoles (HP:0003805) | 2.50457221 |
| 66 | Increased muscle lipid content (HP:0009058) | 2.48524999 |
| 67 | Deformed tarsal bones (HP:0008119) | 2.48520133 |
| 68 | Mitochondrial inheritance (HP:0001427) | 2.48412153 |
| 69 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.45982182 |
| 70 | Bulbar palsy (HP:0001283) | 2.44994325 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 2.43913889 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.43913889 |
| 73 | Palmoplantar keratoderma (HP:0000982) | 2.41286874 |
| 74 | Testicular atrophy (HP:0000029) | 2.37056456 |
| 75 | Increased CSF lactate (HP:0002490) | 2.35988267 |
| 76 | Progressive muscle weakness (HP:0003323) | 2.35633472 |
| 77 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.33374247 |
| 78 | Abnormality of alanine metabolism (HP:0010916) | 2.33374247 |
| 79 | Hyperalaninemia (HP:0003348) | 2.33374247 |
| 80 | Conjunctival hamartoma (HP:0100780) | 2.33305666 |
| 81 | Exercise intolerance (HP:0003546) | 2.28053474 |
| 82 | Lower limb amyotrophy (HP:0007210) | 2.26431164 |
| 83 | Malignant hyperthermia (HP:0002047) | 2.18006322 |
| 84 | Lactic acidosis (HP:0003128) | 2.17992073 |
| 85 | Increased intramyocellular lipid droplets (HP:0012240) | 2.17937298 |
| 86 | Distal lower limb amyotrophy (HP:0008944) | 2.16054558 |
| 87 | Hypoplastic ischia (HP:0003175) | 2.15971908 |
| 88 | Abnormal finger flexion creases (HP:0006143) | 2.13749817 |
| 89 | Facial diplegia (HP:0001349) | 2.13123501 |
| 90 | Ketosis (HP:0001946) | 2.11597701 |
| 91 | Muscular dystrophy (HP:0003560) | 2.11145979 |
| 92 | Weak cry (HP:0001612) | 2.11019086 |
| 93 | Respiratory failure (HP:0002878) | 2.09805576 |
| 94 | Pheochromocytoma (HP:0002666) | 2.08246943 |
| 95 | Distal arthrogryposis (HP:0005684) | 2.05845517 |
| 96 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.02764715 |
| 97 | Gowers sign (HP:0003391) | 2.01435170 |
| 98 | Myopathic facies (HP:0002058) | 2.01053860 |
| 99 | Ragged-red muscle fibers (HP:0003200) | 1.98215599 |
| 100 | EMG: neuropathic changes (HP:0003445) | 1.96730602 |
| 101 | Foot dorsiflexor weakness (HP:0009027) | 1.95428351 |
| 102 | Abnormality of the foot musculature (HP:0001436) | 1.94952185 |
| 103 | Generalized muscle weakness (HP:0003324) | 1.91121286 |
| 104 | Large for gestational age (HP:0001520) | 1.90657051 |
| 105 | Neoplasm of head and neck (HP:0012288) | 1.89718162 |
| 106 | Esophageal neoplasm (HP:0100751) | 1.89718162 |
| 107 | Round ear (HP:0100830) | 1.89700062 |
| 108 | Hamartoma of the eye (HP:0010568) | 1.88398325 |
| 109 | Abnormality of the ischium (HP:0003174) | 1.88031778 |
| 110 | Waddling gait (HP:0002515) | 1.87958693 |
| 111 | Neuroendocrine neoplasm (HP:0100634) | 1.87326705 |
| 112 | Proximal amyotrophy (HP:0007126) | 1.87150983 |
| 113 | Hip contracture (HP:0003273) | 1.87093438 |
| 114 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86698840 |
| 115 | Congestive heart failure (HP:0001635) | 1.86641737 |
| 116 | Sudden cardiac death (HP:0001645) | 1.84870510 |
| 117 | Hyperkalemia (HP:0002153) | 1.84734928 |
| 118 | Dysmetric saccades (HP:0000641) | 1.84053910 |
| 119 | Spinal rigidity (HP:0003306) | 1.81592146 |
| 120 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.80115409 |
| 121 | Abnormality of the neuromuscular junction (HP:0003398) | 1.77436033 |
| 122 | Fatigable weakness (HP:0003473) | 1.77436033 |
| 123 | Slender build (HP:0001533) | 1.75493425 |
| 124 | Steppage gait (HP:0003376) | 1.74716244 |
| 125 | Fetal akinesia sequence (HP:0001989) | 1.65844469 |
| 126 | Limb-girdle muscle weakness (HP:0003325) | 1.59127324 |
| 127 | Increased serum pyruvate (HP:0003542) | 1.55404084 |
| 128 | Abnormality of the calcaneus (HP:0008364) | 1.49119131 |
| 129 | Abnormality of glycolysis (HP:0004366) | 1.45684948 |
| 130 | Abnormality of the tricuspid valve (HP:0001702) | 1.43149245 |
| 131 | Oligomenorrhea (HP:0000876) | 1.40391957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.78853268 |
| 2 | OBSCN | 5.05805210 |
| 3 | PHKG2 | 4.45100769 |
| 4 | PHKG1 | 4.45100769 |
| 5 | PDK3 | 3.73493843 |
| 6 | PDK4 | 3.73493843 |
| 7 | LMTK2 | 3.48592018 |
| 8 | MYLK | 3.00026679 |
| 9 | DMPK | 2.79639491 |
| 10 | BCKDK | 2.63968805 |
| 11 | PKN2 | 2.63669539 |
| 12 | TRIB3 | 2.49111686 |
| 13 | PINK1 | 2.36321222 |
| 14 | NEK1 | 2.33790384 |
| 15 | PDK2 | 2.33604896 |
| 16 | MUSK | 2.20562796 |
| 17 | PIK3CA | 2.12417176 |
| 18 | TIE1 | 1.82200074 |
| 19 | GRK7 | 1.61135035 |
| 20 | STK24 | 1.47723564 |
| 21 | MARK1 | 1.30959472 |
| 22 | MAP3K7 | 1.25712364 |
| 23 | MAP2K3 | 1.23672232 |
| 24 | PAK3 | 1.21888159 |
| 25 | CAMK2D | 1.18665179 |
| 26 | PRKD1 | 1.16771631 |
| 27 | LIMK1 | 1.13606363 |
| 28 | MAPK12 | 1.09579166 |
| 29 | NME1 | 0.93453167 |
| 30 | ILK | 0.89287528 |
| 31 | PRKAA1 | 0.88685476 |
| 32 | EEF2K | 0.86959897 |
| 33 | MAPKAPK3 | 0.84566265 |
| 34 | PRKAA2 | 0.84411376 |
| 35 | ROCK1 | 0.81293034 |
| 36 | INSRR | 0.79475914 |
| 37 | STK4 | 0.79370556 |
| 38 | TRPM7 | 0.78792241 |
| 39 | ZAK | 0.75816228 |
| 40 | PKN1 | 0.74864030 |
| 41 | FLT3 | 0.74804025 |
| 42 | RIPK1 | 0.74573063 |
| 43 | WNK4 | 0.73296626 |
| 44 | CAMK4 | 0.71612725 |
| 45 | MAP3K6 | 0.71208963 |
| 46 | PIK3CG | 0.71088301 |
| 47 | MAP3K5 | 0.70800781 |
| 48 | CDC42BPA | 0.68849460 |
| 49 | MAP3K3 | 0.67464081 |
| 50 | STK38L | 0.63823790 |
| 51 | NEK9 | 0.62781379 |
| 52 | PDGFRA | 0.61767250 |
| 53 | MAPK4 | 0.58839125 |
| 54 | CAMK2B | 0.56260848 |
| 55 | EPHA3 | 0.55997041 |
| 56 | NME2 | 0.55910364 |
| 57 | CAMK2A | 0.55757210 |
| 58 | STK38 | 0.54037616 |
| 59 | ERBB3 | 0.53526919 |
| 60 | MAP2K1 | 0.53079947 |
| 61 | TGFBR2 | 0.52535740 |
| 62 | DAPK3 | 0.52438250 |
| 63 | EPHB1 | 0.51739929 |
| 64 | MOS | 0.51583327 |
| 65 | ROCK2 | 0.48969529 |
| 66 | KDR | 0.48564880 |
| 67 | WNK1 | 0.48327587 |
| 68 | CCNB1 | 0.47730253 |
| 69 | PRKACB | 0.47372116 |
| 70 | RPS6KL1 | 0.45733091 |
| 71 | RPS6KC1 | 0.45733091 |
| 72 | DYRK1B | 0.44596421 |
| 73 | CAMK2G | 0.43726583 |
| 74 | CAMK1 | 0.42929967 |
| 75 | MAP2K4 | 0.40529573 |
| 76 | KSR2 | 0.39895499 |
| 77 | PDPK1 | 0.38534700 |
| 78 | AKT2 | 0.38522284 |
| 79 | RPS6KA6 | 0.38447035 |
| 80 | PRKACA | 0.37724595 |
| 81 | PRKACG | 0.36577116 |
| 82 | PDK1 | 0.33651754 |
| 83 | PTK2B | 0.32124463 |
| 84 | MAP2K6 | 0.32019396 |
| 85 | PRKCE | 0.31824738 |
| 86 | ICK | 0.31709508 |
| 87 | SGK2 | 0.31572611 |
| 88 | PTK6 | 0.28072606 |
| 89 | MAP3K13 | 0.26657825 |
| 90 | RPS6KA1 | 0.25414074 |
| 91 | PRKCH | 0.25327130 |
| 92 | STK39 | 0.24052430 |
| 93 | MAPK10 | 0.22742429 |
| 94 | MAPK11 | 0.21521331 |
| 95 | SIK1 | 0.21511130 |
| 96 | SGK1 | 0.20507998 |
| 97 | TAOK1 | 0.19724315 |
| 98 | RET | 0.19499659 |
| 99 | JAK1 | 0.19284881 |
| 100 | SGK3 | 0.18831187 |
| 101 | ZAP70 | 0.18468702 |
| 102 | PRKG1 | 0.18123719 |
| 103 | NLK | 0.16878856 |
| 104 | PRPF4B | 0.16766750 |
| 105 | FER | 0.15853147 |
| 106 | LATS2 | 0.15843701 |
| 107 | RPS6KA3 | 0.15800767 |
| 108 | MARK3 | 0.15383310 |
| 109 | FGFR4 | 0.15130533 |
| 110 | TBK1 | 0.15095518 |
| 111 | MAP3K1 | 0.14839272 |
| 112 | LATS1 | 0.14665132 |
| 113 | RPS6KB2 | 0.13602295 |
| 114 | SGK494 | 0.13533355 |
| 115 | SGK223 | 0.13533355 |
| 116 | PRKD3 | 0.13433489 |
| 117 | MAP3K11 | 0.13306438 |
| 118 | MARK2 | 0.13264503 |
| 119 | MTOR | 0.12963791 |
| 120 | MAPK7 | 0.12503242 |
| 121 | LRRK2 | 0.12163081 |
| 122 | STK11 | 0.11733357 |
| 123 | JAK2 | 0.10174324 |
| 124 | PRKG2 | 0.09963704 |
| 125 | EPHB2 | 0.09874467 |
| 126 | PAK6 | 0.09266650 |
| 127 | RPS6KB1 | 0.08906173 |
| 128 | FGFR3 | 0.07458428 |
| 129 | MAPK9 | 0.06286429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.00377582 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.30593497 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.07258213 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.48141047 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.47927533 |
| 6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.44701197 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39771559 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 3.26082109 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.19969081 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.97965528 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.54308184 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51406283 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.46627090 |
| 14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.43856723 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.27386343 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.26270142 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 2.00178971 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.86943264 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62106081 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56013740 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.55298037 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.50346574 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.33878783 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32349078 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.31288656 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17632516 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.12457640 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12404486 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.09302957 |
| 30 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.06725636 |
| 31 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05218781 |
| 32 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.96921921 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91215748 |
| 34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84035299 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82255003 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81406432 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81001915 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.80642297 |
| 39 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73866943 |
| 40 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70962407 |
| 41 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.69706658 |
| 42 | Lysine degradation_Homo sapiens_hsa00310 | 0.68129030 |
| 43 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64272954 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62746177 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 0.59853864 |
| 46 | Focal adhesion_Homo sapiens_hsa04510 | 0.59585869 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58536933 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56741282 |
| 49 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55454141 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53388163 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50135628 |
| 52 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.49260031 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48175522 |
| 54 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47715207 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47286610 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45347805 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41840160 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 0.41618284 |
| 59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41123252 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.40828995 |
| 61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40293115 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40100666 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38627747 |
| 64 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37524558 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 0.35097356 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34186856 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.32951238 |
| 68 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32387939 |
| 69 | Insulin secretion_Homo sapiens_hsa04911 | 0.30492633 |
| 70 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.30329540 |
| 71 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29201948 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28395164 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27825345 |
| 74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27550582 |
| 75 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.26586178 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26420364 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.21695580 |
| 78 | Adherens junction_Homo sapiens_hsa04520 | 0.21078551 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20454053 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.19960579 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.19664615 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.17383385 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17205613 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | 0.17147592 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.17074396 |
| 86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16318922 |
| 87 | Melanogenesis_Homo sapiens_hsa04916 | 0.16286099 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.15993353 |
| 89 | Circadian entrainment_Homo sapiens_hsa04713 | 0.15856846 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.14835993 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.14400473 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13620742 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.12687118 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.11584585 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11002484 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.10861058 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.10136810 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.09403552 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.08386883 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.07895538 |
| 101 | Olfactory transduction_Homo sapiens_hsa04740 | 0.07830141 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.07145788 |
| 103 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.05898884 |
| 104 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.05513348 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.05480258 |
| 106 | Gap junction_Homo sapiens_hsa04540 | 0.05381709 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.05068980 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04993415 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.04214051 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.01777300 |
| 111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.01098371 |
| 112 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | -0.0194350 |
| 113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0163888 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0116212 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | -0.0047825 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0027548 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0025290 |

